Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

[1]  W. Hahn,et al.  Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) Mutation , 2014, Molecular and Cellular Biology.

[2]  W. Grajkowska,et al.  Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study. , 2013, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[3]  W. Foulkes,et al.  DICER1 hotspot mutations in non-epithelial gonadal tumours , 2013, British Journal of Cancer.

[4]  W. Foulkes,et al.  Familial rhabdoid tumour 'avant la lettre'—from pathology review to exome sequencing and back again , 2013, The Journal of pathology.

[5]  J. Yokota,et al.  A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. , 2013, Cancer research.

[6]  C. Stiller,et al.  Extracranial rhabdoid tumours: what we have learned so far and future directions. , 2013, The Lancet. Oncology.

[7]  Y. Fukushima,et al.  Clinical correlations of mutations affecting six components of the SWI/SNF complex: Detailed description of 21 patients and a review of the literature , 2013, American journal of medical genetics. Part A.

[8]  G. Crabtree,et al.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy , 2013, Nature Genetics.

[9]  D. Huntsman,et al.  Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics , 2013, Orphanet Journal of Rare Diseases.

[10]  D. Eccles,et al.  Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas , 2013, Nature Genetics.

[11]  S. Ishikawa,et al.  Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features , 2013, Cancer science.

[12]  Jonathan R. Pollack,et al.  The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers , 2013, PloS one.

[13]  O. Gharbi,et al.  Small Cell Carcinoma of the Ovary of Hypercalcemic Type: A Case Report , 2012, Case reports in oncological medicine.

[14]  J. Carpten,et al.  Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples , 2012, PloS one.

[15]  R. Spang,et al.  Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing , 2012, Nature Genetics.

[16]  Kristian Cibulskis,et al.  A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. , 2012, The Journal of clinical investigation.

[17]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[18]  D. Evans,et al.  Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis , 2012, neurogenetics.

[19]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[20]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[21]  R. Siebert,et al.  Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. , 2011, The American journal of surgical pathology.

[22]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[23]  K. Münstedt,et al.  Small cell carcinoma of the ovary of the hypercalcaemic type: an analysis of clinical and prognostic aspects of a rare disease on the basis of cases published in the literature , 2011, Archives of Gynecology and Obstetrics.

[24]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[25]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[26]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[27]  R. Siebert,et al.  Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. , 2010, American journal of human genetics.

[28]  J. Petty,et al.  Familial small cell carcinoma of the ovary , 2009, Pediatric blood & cancer.

[29]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[30]  O. Tawfik,et al.  Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers , 2007, The Prostate.

[31]  G. Fleischhack,et al.  Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents , 2006, Cancer.

[32]  R. Siebert,et al.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. , 2006, The Journal of molecular diagnostics : JMD.

[33]  P. Clement,et al.  Selected miscellaneous ovarian lesions: small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions , 2005, Modern Pathology.

[34]  W. McCluggage,et al.  Ovarian Neoplasms Composed of Small Round Cells: A Review , 2004, Advances in anatomic pathology.

[35]  McCluggage Wg.  Ovarian Neoplasms Composed of Small Round Cells: A Review , 2004 .

[36]  E. Oliva,et al.  An Immunohistochemical Analysis of Ovarian Small Cell Carcinoma of Hypercalcemic Type , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[37]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[38]  D. Teng,et al.  BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. , 2000, Cancer research.

[39]  M. Longy,et al.  Familial cluster of ovarian small cell carcinoma: a new mendelian entity? , 1996, Journal of medical genetics.

[40]  J. Lamovec,et al.  Familial occurrence of small-cell carcinoma of the ovary. , 1995, Archives of pathology & laboratory medicine.

[41]  E. Oliva,et al.  Small Cell Carcinoma of the Ovary, Hypercalcemic Type: A Clinicopathological Analysis of 150 Cases , 1994, The American journal of surgical pathology.

[42]  C. Mangioni,et al.  Primary ovarian small cell carcinoma: four more cases. , 1993, Gynecologic oncology.

[43]  R. Scully,et al.  Primary Ovarian Small Cell Carcinoma of Pulmonary Type: A Clinicopathologic, Immunohistologic, and Flow Cytometric Analysis of 11 Cases , 1992, The American journal of surgical pathology.

[44]  R. Scully.  Classification of human ovarian tumors. , 1987, Environmental health perspectives.

[45]  A. Talerman,et al.  Poorly differentiated (small cell) carcinoma of the ovary in young women: evidence supporting a germ cell origin. , 1987, Human pathology.

[46]  S. Krane,et al.  Differential cyclic AMP responses to calcitonin among human ovarian carcinoma cell lines: A calcitonin‐responsive line derived from a rare tumor type , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  T. Kudo,et al.  A greatly simplified method of establishing B-lymphoblastoid cell lines. , 1978, Cancer research.

[48]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .

[49]  Atlas of Tumor Pathology , 1954 .

[50]  A. McKenna,et al.  The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. , 2014, Cancer discovery.

[51]  H. Nagatsuka,et al.  Genetic and epigenetic alterations of BRG1 promote oral cancer development. , 2005, International journal of oncology.

[52]  Claude-Alain H. Roten,et al.  Theoretical and practical advances in genome halving , 2004 .

[53]  Gilmore Hr,et al.  Armed Forces Institute of Pathology. , 1968, Oral surgery, oral medicine, and oral pathology.